C]acetylcarnitine were recorded in vivo for 1 min. The kinetic rate constants related to the transformation of acetate into acetylcarnitine were deduced from the 3 s time resolution measurements using two approaches, either mathematical modeling or relative metabolite ratios. Conclusions: The conversion rates from hyperpolarized acetate into acetylcarnitine were quantified in vivo and, although separated by two enzymatic reactions, these rates uniquely defined the activity of ACS. The conversion rates associated with ACS were obtained using two analytical approaches, both methods yielding similar results. General significance: This study demonstrates the feasibility of directly measuring ACS activity in vivo and, since the activity of ACS can be affected by various pathological states such as cancer or diabetes, the proposed method could be used to non-invasively probe metabolic signatures of ACS in diseased tissue.
Introduction
Acetate plays an important role in human and rodent energy metabolism and it is readily taken up by skeletal muscle [1] [2] [3] (see Fig. 1 ). Acetate is a pyruvate dehydrogenase (PDH) independent acetylator of tissue carnitine and free coenzyme A (CoA) [1] and is converted into acetylCoA via a reaction catalyzed by the enzyme acetylCoA synthetase (ACS). The main function of ACS is to provide the cell with acetylCoA, a key molecule for numerous metabolic pathways including fatty acid and cholesterol synthesis and the tricarboxylic acid (TCA) cycle. ACS has been previously shown to be the rate limiting enzyme in the metabolism of acetate [4, 5] .
Pathological and substrate changes have an effect on the activity of ACS, which has been reported to be turned off faster than other CoA dependent enzymes during free CoA decrease. [6] . Its activity increases together with insulin in response to a carbohydrate-rich diet to induce fatty acid synthesis [7] .
Carnitine acetyltransferase (CAT) converts acetylCoA to acetylcarnitine, a reaction which has a well maintained equilibrium [8] . In skeletal muscle, carnitine plays two metabolic roles: on one hand it serves as a shuttle of acetyl groups and long chain fatty acids from the cytosol into mitochondria and thus enabling beta oxidation [9] [10] [11] [12] [13] . On the other hand it can act as a buffer for excess acetylCoA when the rate of acetylCoA generation is greater than its entry into the TCA cycle. The general function of CAT is to balance rapid changes in the acetylCoA/CoA ratio in both the cytoplasmic and mitochondrial compartments [11] . In rat skeletal muscle, 98% to 99% of extra acetylCoA produced is buffered by acetylcarnitine [14] . Since the mitochondrial inner membrane is impermeable to acetylCoA, CAT is essential in the metabolism of acetate, as was shown in canine skeletal muscle [15] . After transformation to acetylcarnitine it traverses the inner mitochondrial membrane via acetylcarnitine translocase (ATL) where a mitochondrial CAT transfers the acetyl group back to CoASH upon which acetylCoA can enter the TCA cycle.
Acetate, being a short chain fatty acid has a typical plasma concentration of 0.2 mM in rats which decreases during fasting and increases in a diabetic state [5] . Its oxidation has been deemed significant since it is rapidly cleared from the blood if injected in vivo or generated from precursors such as ethanol in the liver [16] . Acetate uptake by resting skeletal muscle is driven by a concentration gradient and is proportional to the plasma concentration [17, 18] . In a single passage of blood, half of the acetate presented to the tissue was removed by the muscle tissue indicating a high affinity for acetate [5] . In contracting skeletal muscle however, acetate oxidation decreased, indicating a shift of substrate preference compared to resting skeletal muscle [19] .
To date, most of the information concerning these enzyme activities in rat has however been collected from cell cultures and tissue preparations [5, 20] . The ability to measure ACS and CAT activities in vivo is expected to provide valuable insight in normal and pathological conditions. 13 C magnetic resonance spectroscopy (MRS) is a well-established technique to investigate in vivo metabolic processes [21] and it can be coupled with standard MR imaging techniques that gives anatomical information. The advent of dissolution dynamic nuclear polarization (DNP) allows for the measurement of specific metabolic reactions in real-time, thanks to a sensitivity enhancement of several orders of magnitude [22, 23] , which is now being used in human trials in the investigation of prostate cancer [24] .
The incorporation of 13 C into acetylcarnitine has been reported after the infusion of hyperpolarized 13 C acetate [25] and after the injection of [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]pyruvate [26, 27] . The aim of the present study was to elucidate the enzyme kinetics involved in the in vivo transformation of acetate to acetylcarnitine in rat skeletal muscle, by extracting quantitative kinetic rate constants from the observed [1- 13 C] acetylcarnitine labeling dynamics following the infusion of different substrate concentrations of hyperpolarized [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate.
Material and methods
All chemicals were purchased from Sigma-Aldrich, Basel, Switzerland. [1-
13
C]sodium acetate was dissolved in a concentration ranging from 1.0 to 4.5 M in a 1:2 mixture of d 6 -EtOD/D 2 O containing 33 mM of TEMPO (2,2,6,6-Tetramethyl-1-piperidinyloxy) free radical. 300 μL of the resulting solution was rapidly frozen in liquid nitrogen to form 10 μL beads that were placed in a 5 T custom-designed DNP polarizer [28, 29] . The 13 C nuclear spins were dynamically polarized at 1.02 ± 0.03 K for 2 h using 30 mW of microwave power at 140.18 GHz. The sample was consecutively rapidly dissolved using 6.0 mL of superheated D 2 O and transferred within 2 s to a separator/infusion pump located inside a 9.4 T horizontal bore magnet containing 0.6 mL of phosphate buffered saline and heparin. Subsequently, 1.0 mL of the room-temperature hyperpolarized acetate solution was automatically infused into the animal within 5 s. From in vitro measurements performed inside the separator/infusion pump, it was determined that the 13 C polarization at the time of injection was 13 ± 2% [30] . No physiological changes were observed during the injection.
All animal experiments were conducted according to federal ethical guidelines and were approved by the local regulatory body. Male Sprague Dawley® rats (275-325 g) were anesthetized with 1.5% isoflurane in oxygen (n = 19). A catheter was placed into the femoral vein for intravenous delivery of the hyperpolarized acetate solution. The respiration rate and temperature were monitored and maintained during the experiment.
All experiments were performed with a Direct Drive spectrometer (Agilent, Palo Alto, CA, USA) interfaced to an actively shielded 9.4 T magnet with a 31 cm horizontal bore (Magnex Scientific, Abingdon, UK). A home-built 1 H/ 13 C probe consisting of a pair of 10 mm diameter 1 H surface coils in quadrature mode and a 10 mm diameter 13 C surface coil was placed over the hind leg of the rat to selectively excite and detect skeletal muscle tissue, more specifically, the gastrocnemius muscles. A hollow glass sphere with a 3 mm inner diameter (Wilmad-LabGlass, NJ, USA) was filled with a 1 M [1-13 C]glucose solution and used to adjust the pulse power and set the reference frequency. Once the animal was positioned inside the magnet, ten axial 1 mm thick slices were acquired using a gradient echo sequence (TR = 50 ms, TE = 3 ms, field of view = 30 × 30 mm 2 , matrix = 128 × 128, flip angle = 30°) from which the volume of interest was selected. The static magnetic field was homogenized in a 600 μL (6 × 10 × 10 mm 3 ) voxel to reduce the localized proton line width to 20 Hz using the FASTESTMAP shimming protocol [31] . Series of single-pulse 13 C acquisitions were sequentially recorded starting 12 s after dissolution using 30°adiabatic RF pulses (BIR4) applied every 3 s with 1 C pyruvate reference sample of a known concentration. The animals blood volume was calculated using the relation between total blood volume and body weight published by Lee and Blaufox [32] and the blood [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate concentration was obtained accordingly.
The in vitro spin-lattice relaxation times of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetylcarnitine were also measured at 400 MHz in D 2 O and in freshly collected rat blood at 37°C using a saturation recovery sequence with proton decoupling during acquisition. A non-linear least-squares quantification algorithm, AMARES, as implemented in the jMRUI software package [33] , was used to fit the 13 C NMR data. The spectra were corrected for the phases and DC offset. Soft constraints were imposed to peak frequencies (182.55-182.65 ppm for acetate and 173.85-173.95 ppm for acetylcarnitine) and line widths (FWHM = 5-30 Hz) and the relative phases were fixed to zero. The acetylcarnitine peak areas were normalized to the maximum acetate signal in each experiment to account for varying polarization levels across experiments. The time courses of quantified peak areas were analyzed with the kinetic model described below, implemented in Matlab (The MathWorks, Natick, MA, USA).
Kinetic model of acetate metabolism
The uptake of acetate by skeletal muscle tissue as a function of the arterial concentration is described in [17, 18] . Acetate transport across the cellular membrane occurs by facilitated diffusion, and thus net transport of acetate between the plasma and the tissue depends on the concentration gradient. We therefore assumed that the measured kinetic parameters are independent of processes related to membrane transport. As a result, the variations in conversion rates as a function of the injected concentration are expected to be directly correlated to ACS and CAT activity.
In the simplest model of a biochemical reaction, the conversion from substrate to product in a tissue can be described with a rate constant k that depends on substrate and enzyme concentrations. The assumption is that the enzyme concentration is not influenced by the substrate in the short time scale of the experiment, which is about 1 min. Therefore, the 13 C (*) label flow between the substrate acetate (Ace) and the metabolites acetylCoA (A.CoA) and acetylcarnitine (A.Car) in the skeletal muscle can be described as follows: are the forward and the backward fluxes through CAT, respectively, V ACS is the flux through ACS and V OUT is the flux out of the acetylcarnitine pool (Fig. 1) . Since the physiological plasma acetate concentration is lower than 0.2 mM [5] , it can be assumed that the acetate blood pool was fully labeled following the bolus injection, i.e. [Ace*]/[Ace] ≈ 1. Summing Eqs. (2) and (3) leads to:
The acetylCoA pool size is well regulated and is typically more than 10 times smaller than the acetylcarnitine pool [14] , i.e. a small pool approximation [34, 35] (4) can be neglected since, within the short experimental time frame, the acetylcarnitine pool is only partially labelled and thus a minute amount of 13 C label will reach the mitochondrial acetylCoA pool. This is further supported by a previous study showing that the contribution of acetate to the TCA cycle in skeletal muscle was an order of magnitude smaller than our observed rate of acetylcarnitine formation [36, 37] . Condensing the previous statements, the 13 C flow from acetate to acetylcarnitine in the skeletal muscle can be described by the following two equations:
where the kinetic rate constant of ACS is introduced. Based on these conditions, it was concluded that the observed kinetic rate in these experiments corresponds to the enzymatic activity of ACS. The acetate 13 C NMR signal measured in skeletal muscle tissue following the injection of hyperpolarized [1- 13 C]acetate decayed with time as a consequence of a combination of (a) the loss of spin polarization related to longitudinal relaxation and characterized by an exponential decay rate R 1 , (b) the loss of longitudinal magnetization due to radiofrequency excitations, and (c) the conversion of acetate into acetylcarnitine characterized by the kinetic rate constant k ACS . The acetylcarnitine signal also decays because of (a) and (b), but (c) leads to an increase in signal. The time evolution of the carbonyl 13 C longitudinal magnetization of acetate, M A , and acetylcarnitine, M C , can thus be written as:
where R A , is the acetate signal decay comprising the carbonyl 13 C longitudinal relaxation rate R 1,A as well as the potential [1-
13 C]acetate flow of signal in and out of the volume of interest; R 1,C is the carbonyl 13 C longitudinal relaxation rate of acetylcarnitine: Finally, M A,eq and M C,eq are the thermal equilibrium magnetizations of the carbonyl sites of acetate and acetylcarnitine, respectively. The contributions of M A,eq and M C,eq to the acetate and acetylcarnitine signals can be neglected since M A ≫ M A,eq and M C ≫ M C,eq when the resonances are detectable. These Bloch-McConnell differential equations [38] are identical to the ones derived for the one-compartment non steady-state metabolic model for one site exchange, which has already been shown to be applicable to hyperpolarized substrates [39] . From the initial conditions M C (t = 0) = 0 and M A (t = 0) = M 0 and taking into account the signal losses due to RF excitations, the hyperpolarized acetate and acetylcarnitine signals, S A (t) and S C (t), measured at t = nT R , T R being the repetition time, are given by:
where b = k ACS /(−k ACS −R A + R 1,C ), and θ is the RF pulse flip angle. The time point of the first acetate observation, which also corresponds to the maximum acetate signal, was set to t = 0 prior to fitting the data with the kinetic model. To relate the signals measured in the sensitive volume of the surface coil described by Eqs. (9) and (10) to the cellular concentrations described by Eqs. (4) and (5), it was assumed that the blood volume in the VOI was small enough to neglect its contribution to the measured 13C acetate signal. This was supported by anatomical proton images taken prior to the injections and previous PET studies which determined a small blood volume in this area [40] . This assumption is strengthened by a reported acetate removal of 50% by skeletal muscle in a single passage of blood [5] . The dependence of the reaction kinetics on the hyperpolarized substrate concentration was analyzed using the standard Michaelis-
where K M and V max are the Michaelis constant and the initial reaction rate v 0 is the product of the initial acetate concentration and the kinetic rate constant, i.e., v 0,ACS = k ACS ⋅ [Ace].
It has been observed that there exists a linear relationship between the kinetic rate constants obtained using mathematical modelling and the ratio of the areas of acetylcarnitine and acetate, a linearity also observed in studies using hyperpolarized pyruvate [41] . This linearity in case of hyperpolarized acetate was investigated by analysing the system of coupled equations defined by Eqs. (9) and (10) which has only 3 free parameters, namely k ACS , R A and R 1,C . It is possible to eliminate R A by integrating the two equations over time and by taking their relative ratio as described in the Appendix A, yielding the following relationship:
where S C (nT R ) and S A (nT R ) are the signal intensity obtained at the nth of the N acquisitions, corrected for the loss of signal due to the RF pulses for acetylcarnitine and acetate, respectively, by the term cos θ
.
Results
The incorporation of hyperpolarized 13 C label into acetylcarnitine was detected in all animals (n = 19). The average line width of the acetate resonance at 182.6 ppm was 21 ± 6 Hz and that of the acetylcarnitine resonance at 173.9 ppm was 6 ± 1 Hz (Fig. 2) . The first acetate signal measured corresponds to the maximum observed signal which appeared 13.5 ± 2.3 s after the beginning of the injection and no progressive build-up of the signal was observed. The maximum acetylcarnitine signal was detected at a later time, 26.2 ± 3.9 s after the beginning of the injection. The maximal SNR of acetylcarnitine was 10 with zero line broadening and we imposed a minimum SNR threshold of 3 below which the signal was not taken into account for data analysis.
In each experiment 1.0 mL of hyperpolarized acetate solution, with a concentration ranging from 40 to 290 mM was injected into the femoral vein. It was estimated that the injected hyperpolarized acetate doses resulted in a plasma acetate concentration ranging from 1.8 to 15.0 mM [32] . Using a previously reported relation between plasma and tissue acetate concentration in rat skeletal muscle [17] , it was estimated that the tissue acetate concentration ranged from 0.12 to 1 mM. To determine k ACS from the system of coupled equations defined by Eqs. (7) and (8), the longitudinal relaxation time of [1-13 C] acetylcarnitine was set to its in vitro value at 9.4 T, T 1,C = 1/R 1,C , of 14.9 ± 0.7 s determined in blood at physiological temperature (310 K, 37°C) ( Table 1 ). The T 1 of acetylcarnitine in D 2 O had a value similar to the T 1 in plasma at 310 K. Its T 1 decreases with decreasing temperature (Table 1 ). The kinetic rate constant k ACS was determined by fitting Eqs. (9) and (10) to the time evolution of the acetate and acetylcarnitine signal integrals ( C label is catalyzed by the enzymes ACS and CAT. Spectra were acquired every 3 s using adiabatic 30°excitation pulses and 1 H decoupling during acquisition, a 1.0 mL solution of a 110 mM hyperpolarized acetate was injected. Inset: summation of the spectra as described in Eq. (11) which was used to calculate the kinetic rate constants. To further demonstrate that the kinetic rate constant is uniquely determined when the relaxation rate of acetylcarnitine R 1,C is fixed, k ACS was calculated for all experiments using Eq. (11) and plotted against the kinetic rate constants obtained from the fitting procedure (Fig. 5) . The residual differences are most likely due to the fitting errors inherent to the limited signal-to-noise ratio.
Discussion
The present study demonstrates that kinetic rates for the conversion of acetate to acetylcarnitine can be derived from in vivo hyperpolarized magnetic resonance experiments and that these rates are in very good agreement with the ones determined in in vitro experiments. The plasma acetate concentrations used in the current study (1.8-15.1 mM) have been previously shown to linearly scale with the uptake of acetate in skeletal muscle tissue and thus with the cellular acetate concentration [17, 18] . This implies that the kinetic parameters extracted from the in vivo real-time measurements presented herein are independent of processes related to membrane transport since acetate uptake by resting skeletal muscle is proportional to the arterial concentration. Therefore, the variations in conversion rates as a function of the injected concentration are thus directly correlated to the biochemical transformations regulated by ACS and CAT in the cytosol. CAT also resides in the mitochondria where it converts acetylcarnitine back into acetylCoA followed by entry into the TCA cycle and 13 C MRS cannot distinguish between the two compartments. However, since compared to other substrates there is a relatively small (~3%) contribution of acetate to mitochondrial acetylCoA in the skeletal muscle [36, 37] , and in addition the cytosolic acetylcarnitine pool is only partially labelled during the short duration of the experiments, it is expected that the [1-
13
C] acetylcarnitine signal almost exclusively originates from the cytosol.
The tissue concentrations used in the present study (0.12-1.00 mM) were approximately an order of magnitude lower than those used to maximally acetylate free carnitine and CoA in canine skeletal muscle [15] and human skeletal muscle at rest [42] [43] [44] . This indicates that the observed acetylcarnitine formation was not hindered Acetate Acetylcarnitine Model Fit Fig. 3 . Time course of the normalized peak integrals of hyperpolarized acetate (•) and its metabolic product acetylcarnitine (■). The kinetic model described with Eqs. (9) and (10) was used to fit (---) the hyperpolarized time courses to determine the kinetic rate constant k ACS , and the decay rate of acetate R A . The time courses were normalized to their maximum signal. In the data shown here 1.0 mL of a 110 mM hyperpolarized acetate solution was injected. by a decrease in carnitine availability to CAT. The observed kinetic rate constants range from~2 to 6 ms
, showing that substrate concentration is an important parameter to take into account while designing a study using hyperpolarized acetate as a metabolic tracer. It was also observed that this conversion is not saturated even at a tissue concentration of acetate as high as 1 mM.
Our analysis based on the assumption that, during the experimental time frame, the acetate pool is fully labeled and the time variation of the acetylCoA pool labeling is much smaller than the one of acetylcarnitine led to the conclusion that the kinetic rates corresponds to the conversion rate associated with the enzyme acetylCoA synthetase. This is further supported by the fact that the transformation catalyzed by ACS is the rate-limiting step in the transformation of acetate into acetylcarnitine [4] . It needs to be mentioned that the reaction through ACS is irreversible and there is no direct exchange between acetate and acetylcarnitine. Previous reported ACS activity suggested an in vitro K M of 0.2 mM for acetate [20] . Following acetate infusions in rat and sheep, the Michaelis constant for acetate in the ACS reaction was between 0.28 and 0.39 mM, based on tissue extracts, with no marked differences between species, tissue or the intracellular location of the enzyme activity [5] . These values of K M are in agreement with our observed Michaelis constant.
Based on the linear relationship between the ratio of signal integrals and the kinetic rate constants, two approaches were used to extract k ACS from the data: One was based on time evolution fitting of the signal integrals (Eqs. (9) and (10)) and the other on the relative ratio of the sum of both substrate and product (Eq. (11)). Note that, while the first requires the use of mathematical modeling, the summation approach is simpler but less accurate because each individual spectrum has to be divided by a factor of cos θ (n − 1) according to Eq. (11),
where n is the acquisition number, leading to noise error propagation, whereas the fit of the time series takes into account the RF decay and only relies on raw data. Other approaches based on mathematical modeling of the metabolic time course were previously proposed to determine the conversion rates from hyperpolarized 13 C-labeled pyruvate to its downstream metabolites [39, 45, 46] . Acetylcarnitine 13 C labeling in the heart has been previously reported following the infusion of hyperpolarized [2-
C]pyruvate [26, 27] , but unlike pyruvate, acetate is independent of PDH flux. The utilization of acetate by the TCA cycle is strictly aerobic and depending on the delivery of both acetate and oxygen [5] , the conversion rate constants are expected to be strongly dependent on the oxygenation of the tissue under investigation and TCA cycle activity: It was previously shown that intense muscle activity lead to an accumulation of acetylcarnitine [11] , and that a decreased exchange between acetylcarnitine and acetate was a relevant marker for ischemia [25] . The possibility to monitor the acetylcarnitine kinetics in vivo in a measurement window of 1 min in a non-invasive manner and the extraction of specific enzymatic activities can be expected to be a valuable tool for differentiating between healthy and pathological metabolism, in particular since the conversion rate regulated by ACS is implicated in disorders like diabetes [47] or cancer [48] .
Conclusions
The conversion rates from hyperpolarized acetate into acetylcarnitine can be quantified in vivo, and although separated by two enzymatic reactions, these rates define uniquely the activity of acetylCoA synthetase. It was further shown that these rates can be obtained using either fitting of time courses, or an analysis based on time course integration, both approaches yielded similar enzymatic activity. This study showed the feasibility of measuring the activity of acetylCoA synthetase in vivo.
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